Feline T-lymphotropic lentivirus assay
AssigneeThe Regents of the University of California
InventorsNiels C. Pedersen, Janet K. Yamamoto
Life of this patent
Estimating the term…
Abstract
Compositions derived from a novel viral isolate designated feline T-lymphotropic lentivirus (FTLV) include the whole virus; proteins, polypeptides and, polynucleotide sequences derived from the virus; and antibodies to antigenic sites on the virus. These compositions are useful in a variety of techniques for the detection of and vaccination against FTLV. Detection methods disclosed include immunoassays for both the virus and antibodies to the virus, and the use of polynucleotide probes to detect the viral genome. Vaccines include both wholly and partially inactivated viruses and subunit vaccines. Whole, live virus is also useful as a model system for predicting the behavior of human immunodeficiency virus (HIV).
Claims6
A method for diagnosing viral infection in a susceptible host, said method comprising:
- obtaining a physiological specimen from said host;
- and
- determining the presence of feline T-lymphotropic virus (FTLV) or antibodies to FTLV in a physiological specimen from said host.
A method for diagnosing viral infection in a susceptible host, said method comprising:
- obtaining a physiological specimen from the host;
- exposing the specimen to a solid phase having immobilized antigen characteristic of feline T-lymphotropic virus (FTLV), whereby anti-FTLV antibody in the specimen binds to said immobilized antigen;
- and
- exposing the solid phase to labeled anti- (anti-FTLV) antibody;
- and
- detecting binding of the label to the solid phase, said binding being diagnostic of viral infection.
Dependencies are inferred from the claim text.